Hadjadj et al. demonstrated that patients with severe COVID-19 display a downregulation of IFN-stimulated genes (MX1, IFITM1 and IFIT2) compared to patients with mild and moderate disease severity [47,48,49]. This evidence concerns the gene MX1 and COVID-19.